Insider Trading Alert - IVZ, LII And NXTM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 28, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $529.45 to $86,394,898.20.

Highlighted Stocks Traded by Insiders:

Invesco (IVZ) - FREE Research Report

Lawrence Edward P, who is Director at Invesco, sold 2,500 shares at $40.32 on May 28, 2015. Following this transaction, the Director owned 30,405 shares meaning that the stake was reduced by 7.6% with the 2,500-share transaction.

The shares most recently traded at $40.04, down $0.28, or 0.7% since the insider transaction. Historical insider transactions for Invesco go as follows:

  • 4-Week # shares sold: 37,208
  • 12-Week # shares sold: 81,434
  • 24-Week # shares sold: 206,802

The average volume for Invesco has been 2.5 million shares per day over the past 30 days. Invesco has a market cap of $17.4 billion and is part of the financial sector and financial services industry. Shares are up 2.07% year-to-date as of the close of trading on Thursday.

Invesco Ltd. is a publicly owned investment manager. The stock currently has a dividend yield of 2.67%. The company has a P/E ratio of 16.5. Currently, there are 10 analysts who rate Invesco a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IVZ - FREE

TheStreet Quant Ratings rates Invesco as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Invesco Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Lennox International (LII) - FREE Research Report

Johnston Terry L, who is President and COO, Commercial at Lennox International, sold 6,677 shares at $113.33 on May 28, 2015. Following this transaction, the President and COO, Commercial owned 22,515 shares meaning that the stake was reduced by 22.87% with the 6,677-share transaction.

The shares most recently traded at $112.74, down $0.59, or 0.53% since the insider transaction. Historical insider transactions for Lennox International go as follows:

  • 4-Week # shares sold: 500
  • 12-Week # shares sold: 102,897
  • 24-Week # shares sold: 151,694

The average volume for Lennox International has been 417,100 shares per day over the past 30 days. Lennox International has a market cap of $5.2 billion and is part of the industrial goods sector and industrial industry. Shares are up 19.83% year-to-date as of the close of trading on Thursday.

Lennox International Inc., through its subsidiaries, designs, manufactures, and markets climate control products for the heating, ventilation, air conditioning, and refrigeration markets. The stock currently has a dividend yield of 1.25%. The company has a P/E ratio of 26.8. Currently, there are 10 analysts who rate Lennox International a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LII - FREE

TheStreet Quant Ratings rates Lennox International as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and poor profit margins. Get the full Lennox International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

NxStage Medical (NXTM) - FREE Research Report

Turk Joseph E Jr, who is President at NxStage Medical, sold 2,000 shares at $16.64 on May 28, 2015. Following this transaction, the President owned 119,663 shares meaning that the stake was reduced by 1.64% with the 2,000-share transaction.

The shares most recently traded at $16.44, down $0.20, or 1.22% since the insider transaction. Historical insider transactions for NxStage Medical go as follows:

  • 4-Week # shares bought: 10,150
  • 4-Week # shares sold: 3,880
  • 12-Week # shares bought: 10,150
  • 12-Week # shares sold: 8,380
  • 24-Week # shares bought: 10,150
  • 24-Week # shares sold: 18,880

The average volume for NxStage Medical has been 484,900 shares per day over the past 30 days. NxStage Medical has a market cap of $1.0 billion and is part of the health care sector and health services industry. Shares are down 9.04% year-to-date as of the close of trading on Thursday.

NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Currently, there are 4 analysts who rate NxStage Medical a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NXTM - FREE

TheStreet Quant Ratings rates NxStage Medical as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and disappointing return on equity. Get the full NxStage Medical Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens